Matthew K. Waldor
6Patents
1h-index
11Co-inventors
48Inventor score
Filing activity: Dec 26, 1984 → Jul 12, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4695459A | Method of treating autoimmune diseases that are mediated by Leu3/CD4 phenotype T cells | Emerging Cross-Sectional Technologies | 46 | Expired |
| US5945285A | Vibrio cholerae having increased sensitivity to antibiotics | Chemistry; Metallurgy | 1 | Expired |
| US11484585B2 | Live attenuated cholera vaccine with probiotic properties | Emerging Cross-Sectional Technologies | 0 | Active |
| US7247437B2 | Vibrionaceae replication factors and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
| US8414903B2 | Escherichia coli mutants and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9845341B2 | Vibro-based delivery system and immune suppression | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.